ICON Announces Executive Leadership Transition

ICON Announces Executive Leadership Transition


ICON plc , a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that, as part of its planned succession of executive leadership, Mr. Ciaran Murray will transition to the role of Chairman of the Board of Directors and Dr. Steve Cutler will be appointed as Chief Executive Officer, with both changes effective as of 1st March 2017. Dr. Cutler joined ICON in 2011 as President, ICON Clinical Research Services.



from Biotech News